MedPath

the effect of psychotherapy and pharmacotherapy on anxiety

Not Applicable
Conditions
Genelized anxiety disorder.
Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is
Registration Number
IRCT201204239544N1
Lead Sponsor
Clinical Psychiatric Research Center- tabriz university of medical science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
16
Inclusion Criteria

Inclusion citeria: Age, at least 18 years and maximum 50 years; generalized anxiety disorder diagnoses based on structured clinical interview based on DSM-VI-TR and confirm the diagnosis according to a psychiatrist or clinical psychologist; having a minimum qualification cycle and ability to read and write and speak fluently. Exclusion criteria: psychotic disorder; obsessive - compulsive disorder; drug dependence; epilepsy syndrome and using any recreational drug and mental health three months before the first treatment session.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: Before treatment, after treatment, 3 month after treatment. Method of measurement: Beck anxiety inventory.
Secondary Outcome Measures
NameTimeMethod
Worry. Timepoint: Before treatment, after treatment, 3 month after treatment. Method of measurement: Pennsylvania State Worry Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath